threonine has been researched along with Glioblastoma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dutta, R; Garg, A; Kale, SS; Sarkar, C; Sharma, MC; Suri, A; Suri, V | 1 |
| Akiyama, T; Hayashi, T; Koyama-Nasu, R; Nasu-Nishimura, Y; Yamanaka, R | 1 |
| Albert, L; Gulati, N; Jhanwar-Uniyal, M; Karsy, M; Murali, R | 1 |
| Cho, BK; Han, SK; Kim, SK; Kim, YW; Lee, CT; Lee, J; Park, KH; Shim, YS; Wang, KC; Yoo, CG | 1 |
| Juhnn, YS; Kang, UG; Kim, SY; Kim, Y; Kim, YS; Lee, YI; Seo, M | 1 |
| Bergh, S; de Groot, JF; Koul, D; Liu, TJ; Lu, Y; Mills, GB; Shen, R; Yung, WK | 1 |
6 other study(ies) available for threonine and Glioblastoma
| Article | Year |
|---|---|
TTF-1: A Well-Favored Addition to the Immunohistochemistry Armamentarium as a Diagnostic Marker of SEGA.
Topics: Astrocytoma; Brain Neoplasms; Child; Ependymoma; Glioblastoma; Humans; Immunohistochemistry; Neurocytoma; Proto-Oncogene Proteins c-akt; Serine; Threonine; Thyroid Nuclear Factor 1; Tuberous Sclerosis | 2022 |
Thr160 of Axin1 is critical for the formation and function of the β-catenin destruction complex.
Topics: Adenomatous Polyposis Coli Protein; Axin Protein; Axin Signaling Complex; beta Catenin; Binding Sites; Biomimetic Materials; Casein Kinase I; Cell Line, Tumor; Glioblastoma; Glycogen Synthase Kinase 3; HEK293 Cells; Humans; Low Density Lipoprotein Receptor-Related Protein-5; Low Density Lipoprotein Receptor-Related Protein-6; Mutagenesis, Site-Directed; Phosphorylation; Protein Stability; RNA, Small Interfering; Threonine; Wnt Signaling Pathway | 2015 |
Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility.
Topics: Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; Antibiotics, Antineoplastic; Carrier Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromones; Enzyme Activation; Fibronectins; Glioblastoma; Humans; Morpholines; Multiprotein Complexes; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Protein Kinases; Proteins; Proto-Oncogene Proteins c-akt; Rapamycin-Insensitive Companion of mTOR Protein; Regulatory-Associated Protein of mTOR; Ribosomal Protein S6 Kinases, 70-kDa; RNA Interference; Serine; Signal Transduction; Sirolimus; STAT3 Transcription Factor; Threonine; Time Factors; TOR Serine-Threonine Kinases | 2009 |
Application of p27 gene therapy for human malignant glioma potentiated by using mutant p27.
Topics: Adenoviridae; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p27; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Genes, Tumor Suppressor; Genetic Therapy; Glioblastoma; Humans; Mutagenesis, Site-Directed; Threonine; Transduction, Genetic; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Proteins | 2004 |
Membrane depolarization induces the undulating phosphorylation/dephosphorylation of glycogen synthase kinase 3beta, and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells.
Topics: Androstadienes; Animals; Calcineurin; Calcium; Cell Line; Cell Line, Tumor; Cell Membrane; Enzyme Inhibitors; Glioblastoma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Humans; Immunoblotting; Immunoprecipitation; Microscopy, Confocal; Naphthalenes; PC12 Cells; Phosphoprotein Phosphatases; Phosphorylation; Potassium Chloride; Rats; Serine; Threonine; Time Factors; Transfection; Wortmannin | 2005 |
Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma.
Topics: Blotting, Western; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Progression; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Fibronectins; G2 Phase; Glioblastoma; Glioma; Humans; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Serine; Signal Transduction; Threonine; Vascular Endothelial Growth Factor A; Vitronectin | 2005 |